XML 57 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Details) - Schedule of stock option activity
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Schedule of stock option activity [Abstract]  
Number of Options, Outstanding at December 31, 2020 (in Shares) | shares 496,471
Weighted Average Exercise Price Per Share, Outstanding at December 31, 2020 $ 8.63
Weighted Average Remaining Contractual Term (years), Outstanding at December 31, 2020 3 years 328 days
Aggregate Intrinsic Value, Outstanding at December 31, 2020 (in Dollars) | $ [1]
Number of Options, Granted (in Shares) | shares 12,756
Weighted Average Exercise Price Per Share, Granted $ 1.84
Weighted Average Remaining Contractual Term (years), Granted 4 years 292 days
Aggregate Intrinsic Value, Granted [1]
Number of Options, Exercised (in Shares) | shares
Weighted Average Exercise Price Per Share, Exercised
Exercised (in Dollars) | $ [1]
Aggregate Intrinsic Value, Exercised (in Dollars) | $ [1]
Number of Options, Forfeited (in Shares) | shares (2,375)
Weighted Average Exercise Price Per Share, Forfeited
Weighted Average Remaining Contractual Term (years), Forfeited [1]
Aggregate Intrinsic Value, Forfeited [1]
Number of Options, Expired (in Shares) | shares
Weighted Average Exercise Price Per Share, Expired
Weighted Average Remaining Contractual Term (years), Expired [1]
Aggregate Intrinsic Value, Exercised, Expired [1]
Number of Options, Outstanding at March 31, 2021 (in Shares) | shares 506,852
Weighted Average Exercise Price Per Share, Outstanding at March 31, 2021 $ 8.15
Weighted Average Remaining Contractual Term (years), Outstanding at March 31, 2021 2 years 109 days
Aggregate Intrinsic Value, Outstanding at March 31, 2021 (in Dollars) | $ [1]
Number of Options, Outstanding, Exercisable at March 31, 2021 (in Shares) | shares 228,481
Weighted Average Exercise Price Per Share, Exercisable at March 31, 2021 $ 14.45
Weighted Average Remaining Contractual Term (years), Exercisable at March 31, 2021 2 years 36 days
Aggregate Intrinsic Value, Outstanding, Exercisable at March 31, 2021 (in Dollars) | $ [1]
[1] The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company’s stock and the exercise price of the underlying options. The estimated stock values used in the calculation were $1.73 and $1.66 per share for the year ended December 31, 2020 and the three months ended March 31, 2021, respectively.